A phase I dose-escalation study of BMS-354825 [dasatinib] in patients with refractory solid tumors
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2007
At a glance
- Drugs Dasatinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Nov 2007 Status change from in progress to completed.
- 06 Sep 2005 New trial record.